FdaApplication
BLA 125326
Identifiers
- fda_app_no: BLA125326
Properties
| Property | Value |
|---|---|
| applicant_name | Novartis Pharmaceuticals Corporation |
| application_type | BLA |
| approval_date | 2009-10-26 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ARZERRA | OFATUMUMAB | 100MG/5ML | INJECTABLE;INJECTION |
| ARZERRA | OFATUMUMAB | 1,000MG/50ML | Injection |
| KESIMPTA | — | 20MG/0.4ML | Injection |
| KESIMPTA | — | 20MG/0.4ML | Injection |
4 products